http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2011502513-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-106 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-15 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6886 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N37-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-53 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-50 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-574 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-09 |
| filingDate | 2008-11-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2011-01-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-2011502513-A |
| titleOfInvention | Methods and compositions for diagnostic use in cancer patients |
| abstract | Disclosed herein are methods and compositions useful for identifying therapies that may provide optimal clinical benefit for cancer patients. For example, a method for identifying a renal cancer patient who can benefit from an anti-cancer therapy other than anti-angiogenic therapy or an anti-cancer therapy in addition to anti-angiogenic therapy, comprising: Determining the expression level of one or more genes or gene products as described, and the expression level of one or more genes or gene products in the sample obtained from the patient as compared to a reference sample An increase in is provided a way to show that the patient can benefit from anti-cancer therapy other than anti-angiogenic therapy or in addition to anti-angiogenic therapy. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2015180879-A |
| priorityDate | 2007-11-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 1784.